Seoul, South Korea

Young Geun Yang

This inventor holds 1 USPTO granted patent. Top assignee: Bioquest, Inc.. Active years: 2015.


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Young Geun Yang in Enzymatic Reactions

Introduction

Young Geun Yang is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of enzymatic reactions involving nucleic acid molecules. His innovative approach has the potential to enhance various applications in biotechnology and molecular biology.

Latest Patents

Young Geun Yang holds a patent for "Methods for performing direct enzymatic reactions involving nucleic acid molecules." This patent describes a method that allows for enzymatic reactions to be performed directly using a biological specimen. The reaction mixture includes a zwitterionic buffer and/or a non-reducing carbohydrate, which prevents the biological specimen from inhibiting the enzymatic reaction. Notably, the nucleic acid molecule present in the biological specimen is not purified before the enzymatic reaction, allowing for the direct use of the specimen.

Career Highlights

Young Geun Yang is currently employed at Bioquest, Inc., where he continues to develop innovative solutions in the field of enzymatic reactions. His work is characterized by a commitment to advancing scientific knowledge and practical applications in biotechnology.

Collaborations

He collaborates with talented individuals such as Jong Yeol Kim and Suhng Wook Kim, who contribute to the innovative environment at Bioquest, Inc. Their teamwork fosters creativity and enhances the development of groundbreaking technologies.

Conclusion

Young Geun Yang's contributions to enzymatic reactions represent a significant advancement in biotechnology. His innovative methods have the potential to revolutionize how nucleic acid molecules are utilized in various applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…